The Board of Directors of GlaxoSmithKline Consumer Nigeria Plc (NSE: GLAXO) and Presco Plc (NSE: PRESCO) passed a series of resolutions at their respective Board meetings.
The Board of GLAXO met on 22nd March 2021, while the Board of PRESCO held its meeting on the 23rd of March, 2021.
PRESCO’s Board of Directors approved the draft audited financial statements of the company for the year ended December 31, 2020 subject to minor amendments for the attention of the Independent Auditors.
- Read also; FY 2020: Lafarge Africa Plc posts 98.8% rise in profit from continuing operations
- Airtel Africa Plc sells its telecommunications tower companies in four countries
The audited financial statements of the palm oil producer will be uploaded to the Nigerian Stock Exchange and the Investing public on or before Wednesday March 31, 2021.
At the end of its meeting, the Board of GlaxoSmithKline Consumer Nigeria Plc approved the following resolutions;
- The Audited Financial Statements of GlaxoSmithKilne Consumer Nigeria Plc for the year ended 31st December 2020.
- The Dividends to be proposed to Shareholders at the Annual General Meeting.
The closed period for both companies will terminate 24 hours after the released of the approved Audited Financial Statements to the Market.
Nnamdi Maduakor is a Writer, Investor and Entrepreneur
